Litcius/Paper detail

A Journey Through JAK Inhibitors for the Treatment of Myeloproliferative Diseases

Andrea Duminuco, Elena Torre, Giuseppe A. Palumbo, Claire Harrison

2023Current Hematologic Malignancy Reports24 citationsDOI

Topics & Concepts

MyelofibrosisMedicineRuxolitinibHematologyInternal medicineMyeloproliferative DisordersOncologyBone marrowIntensive care medicineImmunologyMyeloproliferative Neoplasms: Diagnosis and TreatmentKruppel-like factors researchAcute Myeloid Leukemia Research
A Journey Through JAK Inhibitors for the Treatment of Myeloproliferative Diseases | Litcius